|Piper Jaffray & Co.||Edward A. Tenthoff||212-284-9403|
|H.C. Wainwright & Co.||Ed Arce||212-916-3963|
|Oppenheimer & Co Inc.||Jay Olson||212-667-8126|
|Leerink||Joseph P. Schwartz||617-918-4575|
|Roth Capital Partners||Yasmeen Rahimi||646-616-2787|
|Evercore ISI||Josh Schimmer||292-497-0856|
|Raymond James||Steve Seedhouse||212-885-1837|
CymaBay Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CymaBay Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of CymaBay Therapeutics or its management. CymaBay Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.